Drug

Lu AF35700 clinical trials

studies test it: 13
open now: 0
in phase 3: 3
first study started: 2013

How studies write it

Studies that test it under each name

Name

Lu AF35700: 9

Studies by the year they started

13 studies that test it; most in 2017 (5)

Studies that test Lu AF35700, by start year
Year	Studies
2013	1
2014	2
2016	3
2017	5
2018	2

By phase

A phase 1/2 study counts in both.

Phase 1: 10
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it.

Schizophrenia: 4
Schizophrenia, Treatment-Resistant: 2
Renal Insufficiency: 1

Who runs them

Industry 13 · Other 0

H. Lundbeck A/S (13)

Often tested with

Tested in the same studies.

Risperidone (2) · Olanzapine (2) · Itraconazole (1) · Quetiapine (1) · Midazolam (1)

Studies

Open first, then newest update. How each study uses Lu AF35700 is read from its arms, and is right about nine times in ten.

Testing it · 13

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With SchizophreniaCompletedPhase 3H. Lundbeck A/SNCT02892422Written as Lu AF35700
Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700CompletedPhase 1H. Lundbeck A/SNCT02333487Written as Lu AF35700
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaTerminatedPhase 3H. Lundbeck A/SNCT03230864Written as Lu AF35700
Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaCompletedPhase 3H. Lundbeck A/SNCT02717195Written as Lu AF35700
Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed StateCompletedPhase 1H. Lundbeck A/SNCT03670082Written as Lu AF35700
Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and WomenCompletedPhase 1H. Lundbeck A/SNCT03103646Written as Lu AF35700
Pharmacokinetics of Lu AF35700 in Subjects With Renal ImpairmentTerminatedPhase 1H. Lundbeck A/SNCT03241147Written as Lu AF35700
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective DisorderCompletedPhase 1H. Lundbeck A/SNCT02901587Written as Lu AF35700 (10 mg/day)
Bioequivalence Study of Lu AF35700CompletedPhase 1H. Lundbeck A/SNCT03394482Written as Lu AF35700 5 mg clinical formulation
Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy SubjectsCompletedPhase 1H. Lundbeck A/SNCT03189615Written as Lu AF35700
Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing EnzymesCompletedPhase 1H. Lundbeck A/SNCT03195946Written as Lu AF35700
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With SchizophreniaCompletedPhase 1H. Lundbeck A/SNCT02202226Written as Lu AF35700
D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer CompoundCompletedPhase 1H. Lundbeck A/SNCT02093169Written as Part A: Lu AF35700